肠易激综合征的心理治疗

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

参考文献

[1] T ACK J,FR I ED M,HOUGHT ON LA,et al1Syste matic revie w:the

efficacy of treat m ent f or irritable bowel syndr ome2a Eur opean per2

s pective[J]1A li m ent Phar macol Ther,2006,2492):1831

[2] E VANS BW,CLARK W K,MOORE DJ,et al1Tegaser od f or the

treat m ent of irritable bowel syndr ome and chr onic consti pati on[J]1

Cochrane Database Syst Rev,2007,(4):CD0039601

[3] CHEY WD,P ARE’P,V I EG AS A,et al1Tegaser od for fa male pa2

tients suffering fr om I B S with m ixed bowel habits or consti pati on:a

random ized contr olled trial[J]1Am J Gastr oenter ol,2008,103(5):

12171

[4] BOTT OL I I,T OUG AS G,DUNGER2BALDAUF C,et al1Efficacy of

tegaser od over12months in I B S2C patients:do res ponders at3

months still res pond at month12[J]1Gastr oenter ol ogy,2005,128:

T11331

[5] CA M I L LER IM,KERSTE NS R,RYKX A,et al1A Placebo2contr olled

trial of p rucal opride for severe chr onic consti pati on[J]1N EngI J

Med,2008,358(22):23441

[6] ANDRESE N V,MONT OR I V M,KE LLER J,et al1Effectis of52hy2

dr oxytry p ta mine(ser ot onin)ty pe3antag onists on sy mp t o m relief and

consti pati on in nonconsti pated irritable bo wel syndr o me:a syste matic

revie w and meta2analysis of random ized contr olled trials[J]1Clin

Gastr oenter ol Hepat ol,2008,6(5):5451

[7] H I RAT A T,F UNATS U T,KET O Y,et al1I nhibit ory effects of ra mo2

setr on,a potent and selective52HT32recep t orantagonist,on condi2

ti oned tear stress2induced abnor mal defecati on and nor mal defecati on

in rats:comparative studies with antidiarrheal and s pas molytic agents

[J]1J Phar macol Sci,2008,106(2):2641

[8] KI M HS,CHO I EJ,P ARK H1The effect of mosap ride citrate on p r2

oxi m al and distal col onic mot or functi on in the guinea2p ig in vitr o

[J]1Neur ogastr oenter olMotil,2008,20(2):1691

[9] GEORGE AM,MEYERS NL,H I CK L I N G R I1Clinical trial:renza2

p ride therapy f or consti pati on2p redom inant irritable bowel syndr ome2

multicentre,random ized,p lacebo2contr olled,double2blind study in

p ri m ary healthcare setting[J]1A li m ent Phar macol Ther,2008,27

(9):8301

[10] L I M HC,KI M YG,L I M JH,et al1Effect of it op ride hydr ochl oride on

the ileal and col onic motility in Guinea p ig in vitr o[J]1YouseiMed

J,2008,49(3):4721

[11] DELVAUX M,LOUVEL D,LAGI ER E,et al1The kappa agonist fe2

dot ozine relieves hypersensitivity t o col onic distenti on in patients

with irritable bowel syndr ome[J]1Gastr oenter ol ogy,1999,116(1):

381

[12] MANGE L AW,BORNSTE I N JD,HAMM LR,et al1Clinical trial:

asi m adoline in the treat m ent of patients with irritable bowel syn2

dr ome[J]1A li m ent Phar macol Ther,2008,28(2):2391

[13] CROW ELL MD,HARR I S LA,D I B A I SE JK,et al1Activati on of type2

2chl oride channels:a novel therapeutic target for the treat m ent of

chr onic consti on[J]1Curr Op in I nvestig D rugs,2007,8(1):661 [14] JOHANNS ON JF,MORT ON D,GEENEN J,et al1Multicenter,42w2

eek,double2blind,random ized,p lacebo2contr olled trial of lubi p r os2

t one,a l ocally2acting type22chl oride channel activat or,in patients

with chr onic consti pati on[J]1Am J Gastr oenter ol,2008,103(1):

1701

[15] CRE MON I N I F,CAM I L LER IM,McKI N ZI E S1Effect of CCK21an2

tagonist,dexl oxiglum ide,in female patients with irritable bowel syn2

dr ome:a phar macodyna m ic and phar macogenom ic study[J]1Am J

Gastr oenter ol,2005,100(4):6521

(收稿日期:2008208205)

肠易激综合征的心理治疗

朱良如,侯晓华 (华中科技大学同济医学院附属协和医院消化内科,武汉 430022)

关键词: 肠易激综合征; 心理治疗

[中图分类号]R57414 [文献标志码]A [文章编号]10052541X(2008)052270203

精神心理因素在肠易激综合征(irritable bowel syndr o me,I B S)发病中的重要作用日益受到临床医师的重视。据统计40%~50%的I B S患者有心理障碍表现,其中以焦虑、抑郁、癔病多见。这些情绪障碍开始出自于病人对疾病的不理解和担忧,而这种担忧和焦虑又加重了肠道的症状,形成了恶性循环,约80% I B S患者病情发作和加重与精神心理因素有关[1]。

I B S难以治愈,尚无法实现临床症状的完全消失。临床治疗多集中于给予促动力药、解痉药、通便药、调整肠功能药及杀菌制剂药,而忽视了对精神心理因素的关注,治疗效果常常并不理想,致使病程迁延,反过来又加重了病人的情绪障碍,甚至失去了对治疗的信心,因此重视对I B S患者的心理治疗具有重大意义[2]。心理治疗的目标不是治愈疾病,而是消除病人对疾病的恐惧心理,树立战胜疾病的信心;减少病人心理情感应激的频率和强度;缓解临床症状,减少症状发作的频率和严重程度,提高其生活质量;减少病人反复就诊的次数,减轻社会的医疗资源和经济压力[3]。

相关文档
最新文档